Quick Takeaways
- Decibel Therapeutics, Inc. has 13 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 13 Insiders of Decibel Therapeutics, Inc.
- Location
- Boston, MA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 10 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Decibel Therapeutics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Matthew C. Kapusta | Director | Mixed | 25 Sep 2023 | |||
| James B. Murphy | Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney | Mixed | 07 Oct 2022 | |||
| Sara Nochur | Director | Mixed | 25 Sep 2023 | |||
| Elisabeth Leiderman | Chief Financial Officer | Mixed | 25 Feb 2022 | |||
| Peter A. Thompson | Director, 10%+ Owner | Mixed | 17 Jun 2022 | |||
| Cynthia W. Hu | General Counsel | Mixed | 16 Aug 2021 | |||
| William H. Carson | Director | Mixed | 25 Sep 2023 | |||
| Neil Exter | Director, 10%+ Owner | Mixed | 17 Jun 2022 | |||
| Anna Trask | Chief People Officer | Mixed | 25 Sep 2023 | |||
| Alison Cecily Finger | Director | Mixed | 25 Sep 2023 | |||
| John Jui-Jen Lee | Chief Development Officer | Mixed | 25 Sep 2023 | |||
| Kevin F. Mclaughlin | Director | Mixed | 25 Sep 2023 | |||
| Laurence Reid | President and Chief Executive Officer, Director | Mixed | 25 Sep 2023 |
Top shareholders of Decibel Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cynthia W. Hu |
3/4/5
|
General Counsel |
—
class O/S missing
|
150,000
|
— | — | 16 Aug 2021 | |
| Elisabeth Leiderman |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
52,500
|
— | — | 25 Feb 2022 | |
| Neil Exter |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,000
|
— | — | 17 Jun 2022 | |
| Peter A. Thompson |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,000
|
— | — | 17 Jun 2022 |
Recent Insider Transactions by Companies or Individuals for Decibel Therapeutics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.